Armenia vs Papua New Guinea: Access to anti-retroviral drugs, female
Armenia
52.0%
in 2024
Papua New Guinea
51.0%
in 2024
Armenia rank
116th
Papua New Guinea rank
118th
Access to anti-retroviral drugs, female over time
- Armenia
- Papua New Guinea
How they compare
Armenia currently reports 52.0% against 51.0% in Papua New Guinea, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Papua New Guinea ahead.
Armenia ranks 116th and Papua New Guinea ranks 118th of 141 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Papua New Guinea in 2.
Head to head by decade
| Decade | Armenia | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 3.8% | 1.8% | Papua New Guinea |
| 2010s | 27.2% | 30.4% | 3.2% | Papua New Guinea |
| 2020s | 48.6% | 46.2% | 2.4% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Armenia or Papua New Guinea?
- Armenia, at 52.0% against 51.0% in Papua New Guinea as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Armenia and Papua New Guinea?
- 1.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Papua New Guinea?
- 25 years are reported by both, from 2000 to 2024.
- How do Armenia and Papua New Guinea rank globally for access to anti-retroviral drugs, female?
- Armenia ranks 116th and Papua New Guinea ranks 118th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.